EPEmanuele Porru

Emanuele Porru

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emanuele Porru has a total of 141 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploratory Metabolomic and Metagenomic Profiling of Fecal Samples in Isolated REM Sleep Behavior Disorder

    by Fabio Ascari, Luca Baldelli, Daniel Scicchitano, Camilla Pellegrini, Francesco Ravaioli, Sara De Fanti, Erika Esposito, Emanuele Porru, Felice Di Laudo, Raffaele Lodi, et al.

    Isolated REM sleep behavior disorder (iRBD) is among the most reliable prodromal markers of α-synucleinopathies. Under the body-first (gut-first) model of α-synuclein pathology, in which pathology may originate in the enteric nervous system and ascend to the brain, the gut is a biologically plausible compartment in which early and accessible molecular alterations might be detectable; however, the fecal metabolome remains poorly investigated in this population. In this exploratory, cross-sectional study of 21 iRBD patients and 15 healthy controls, we characterized fecal samples through an integrated multi-omics framework. The fecal metabolome was profiled on two complementary mass spectrometry platforms: HS-SPME GC-EI-high-resolution MS, used for both untargeted volatilomics and targeted quantification of linear and branched short-chain fatty acids, and untargeted LC-MS/MS for the non-volatile fraction. Gut microbial community composition was characterized on the same material by 16S rRNA gene sequencing, and the metabolomic and microbial layers were combined by DIABLO multi-omics integration. Linear short-chain fatty acids were preserved, whereas branched-chain fatty acids were selectively increased in iRBD, indicating a shift toward proteolytic fermentation. Volatile indole was reduced, while p-cresol and 2-octanone were increased, paralleled at the LC-MS/MS level by attenuation of the tryptophan–indole axis, class-level bile acid depletion, and increased acylcarnitines. The microbiome was depleted of Blautia and Faecalibacterium and enriched in Oscillospirales. Integration resolved a coherent host-microbe signature that discriminated iRBD patients from controls within this discovery cohort (84.8% cross-validated accuracy). These cross-sectional findings characterize candidate fecal signatures associated with iRBD; given the exploratory design and the limited sample size, they are hypothesis-generating, and their value for predicting phenoconversion remains to be established in prospective studies.

  • Open Access

    Exploratory Metabolomic and Metagenomic Profiling of Fecal Samples in Isolated REM Sleep Behavior Disorder

    by Fabio Ascari, Luca Baldelli, Daniel Scicchitano, Camilla Pellegrini, Francesco Ravaioli, Sara De Fanti, Erika Esposito, Emanuele Porru, Felice Di Laudo, Raffaele Lodi, et al.

    Isolated REM sleep behavior disorder (iRBD) is among the most reliable prodromal markers of α-synucleinopathies, yet accessible biomarkers of phenoconversion risk are lacking and the fecal metabolome remains poorly investigated in this population. In this exploratory, cross-sectional study of 21 iRBD patients and 15 healthy controls, we characterized fecal samples through an integrated multi-omics framework. The fecal metabolome was profiled on two complementary mass spectrometry platforms: HS-SPME GC-EI-high-resolution MS, used for both untargeted volatilomics and targeted quantification of linear and branched short-chain fatty acids, and untargeted LC-MS/MS for the non-volatile fraction. Gut microbial community composition was characterized on the same material by 16S rRNA gene sequencing, and the metabolomic and microbial layers were combined by DIABLO multi-omics integration. Linear short-chain fatty acids were preserved, whereas branched-chain fatty acids were selectively increased in iRBD, indicating a shift toward proteolytic fermentation. Volatile indole was reduced, while p-cresol and 2-octanone were increased, paralleled at the LC-MS/MS level by attenuation of the tryptophan-indole axis, class-level bile acid depletion, and increased acylcarnitines. The microbiome was depleted of Blautia and Faecalibacterium and enriched in Oscillospirales. Integration resolved a coherent host-microbe signature discriminating groups with 84.8% cross-validated accuracy, positioning fecal metabolomics as a sensitive window into prodromal gut-brain interactions.

  • Open Access

    A Comprehensive GC-MS Approach for Monitoring Legacy and Emerging Halogenated Contaminants in Human Biomonitoring

    by Rossana Comito, Nicholas Kassouf, Alessandro Zappi, Nicolò Interino, Emanuele Porru, Jessica Fiori, Dora Melucci, Francesco Saverio Violante

    Human exposure to persistent organic pollutants such as polychlorinated biphenyls (PCB) and brominated flame retardants (BFR), including both legacy and emerging compounds, remains a concern due to their bioaccumulative nature and potential health effects. Comprehensive analytical methods are necessary to monitor these substances in complex biological matrices, such as human serum. A gas chromatography–mass spectrometry (GC-MS) method was developed for the simultaneous determination of 44 analytes, encompassing PCB and a broad spectrum of BFR with diverse physicochemical properties. The extraction procedure and GC-MS parameters were optimized using a design of experiments approach to maximize performance while minimizing analysis time. The method demonstrated high sensitivity, precision, and accuracy, thereby meeting internationally recognized validation criteria for biomonitoring applications. To further ensure analytical reliability, compound confirmation was achieved using gas chromatography–high-resolution mass spectrometry, providing enhanced selectivity and confidence in identification, particularly for low-level analytes. Key advantages of the method include its applicability to analytes with significantly different chemical behaviors and its capacity to quantify a large number of target compounds simultaneously. This makes it a powerful tool for assessing human exposure to both regulated and emerging halogenated contaminants.


  • Open Access

    Mass Spectrometry Quantification of Epigenetic Changes: A Scoping Review for Cancer and Beyond

    by Rossana Comito, Agnese Mannaioli, Agen Peter Lunghi Msemwa, Francesca Bravi, Carlotta Zunarelli, Eva Negri, Emanuele Porru, Francesco Saverio Violante

    Mass spectrometry has become an indispensable tool for the identification and quantification of epigenetic modifications, offering both high sensitivity and structural specificity. The two major classes of epigenetic modifications identified—DNA methylation and histone post-translational modifications—play fundamental roles in cancer development, underscoring the relevance of their precise quantification for understanding tumorigenesis and potential therapeutic targeting. In this scoping review, we included 89 studies that met the inclusion criteria for detailed methodological assessment. Among these, we compared pre-treatment workflows, analytical platforms, and acquisition modes employed to characterize epigenetic modifications in human samples and model systems. Our synthesis highlights the predominance of bottom-up strategies combined with Orbitrap-based platforms and data-dependent acquisition for histone post-translational modifications, whereas triple quadrupole mass spectrometers were predominant for DNA methylation quantification. We critically evaluate current limitations, including heterogeneity in validation reporting, insufficient coverage of combinatorial post-translational modifications, and variability in derivatization efficiency.


  • Open Access

    Real-Life Assessment of Multi-Pollutant Exposure and Its Impact on the Ocular Surface: The Bike-Eye Pilot Study on Urban Cyclists in Bologna

    by Roberto Battistini, Natalie Di Geronimo, Emanuele Porru, Valeria Vignali, Andrea Simone, Suzanne Clougher, Silvia Odorici, Francesco Saverio Violante, Luigi Fontana, Piera Versura

    Background: Urban air pollution, particularly fine particulate matter (PM2.5 and PM10), poses health risks, including damage to the ocular surface. This pilot study (BIKE-EYE) aimed to assess ocular exposure to airborne pollutants during bicycle commuting and to evaluate particle presence in human tear fluid. Methods: Fifteen healthy volunteers wore portable sensors measuring PM2.5 and PM10 during daily bike commutes over six months. Exposure was calculated as time-weighted integrals over the ten days preceding an ophthalmologic exam assessing conjunctival hyperemia, epithelial damage, tear film quality, and meibomian gland function. Ocular symptoms were assessed via the Ocular Surface Disease Index (OSDI). Tear samples were analyzed using scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS). Results: Higher pollutant exposure was significantly associated with conjunctival hyperemia and corneal epithelial damage, while temperature and humidity showed no effect. OSDI scores moderately correlated with PM levels. SEM/EDS analysis confirmed airborne particles in post-exposure tear samples, including carbonaceous material, aluminosilicates, iron, and sulfur compounds. Conclusions: Ocular surface alterations and conjunctival hyperemia were significantly associated with air pollution exposure, while subjective symptoms showed weaker trends. The detection of particulate matter in human tear fluid supports the use of the ocular surface as a sensitive, non-invasive tool for biomonitoring. These findings highlight its potential role in early warning systems for pollution-related health effects, with implications for public health surveillance and urban planning.


  • Open Access

    Upcycling of Citrus Waste by Natural Deep Eutectic Solvents: Green Extraction of Bioactive Compounds with Antioxidant and Regenerative Properties on Human Keratinocytes

    by Alessia Silla, Angela Punzo, Rossana Comito, Emanuele Porru, Greta Gozzi, Maria Cristina Barbalace, Matteo Perillo, Antonello Lorenzini, Marco Malaguti, Silvana Hrelia, et al.

    Background: The citrus processing industry generates over 40 million tons of waste annually, representing a significant environmental challenge. Citrus by-products are rich in bioactive compounds with proven health benefits. This study aims to upcycle citrus waste by developing green extracts and evaluating their biological activities for cosmeceutical applications. Methods: Three NaDES formulations—choline chloride–urea (ChCl: U), choline chloride–citric acid (ChCl: CA), and betaine–urea (Bet: U)—were optimized to extract polyphenols from orange and lemon waste using roller agitation. Extracts were characterized by HPLC–ESI–MS/MS. Biological activities were assessed in human keratinocytes (HaCaT). Antioxidant activity was measured using a chemiluminescent assay that detects intracellular H2O2 production. The wound-healing potential was evaluated using scratch assays, and cytokine release (IL-6, IL-8, IL-1β, IL-10) was assessed by ELISA. DNA damage protection was evaluated by quantifying 53BP1 foci following genotoxic exposure (neocarzinostatin). Results: All NaDES extracts showed high polyphenol content, with hesperidin being the primary compound. Pretreatment with the extracts for 24 h significantly reduced intracellular H2O2 levels, confirming their antioxidant efficacy. In scratch assays, extracts enhanced wound closure; notably, the Bet: U-derived orange extract achieved complete closure within 48 h. All extracts increased IL-6 and IL-8 release, consistent with an early pro-regenerative response. Pretreatment with the Bet: U orange extract lowered the number of cells with high 53BP1 foci after genotoxic stress, indicating partial DNA damage protection. Conclusions: These findings highlight citrus by-product extracts as sustainable bioactive ingredients with great potential for skin repair and anti-aging formulations, promoting responsible cosmeceutical innovation.


  • Open Access

    Tear Sampling and Biomarker Discovery: A Robust Workflow for Routine Clinical Applications Using UHPLC-MS/MS and Schirmer Strips

    by Rossana Comito, Carmen Ciavarella, Gloria Astolfi, Matteo Conti, Emanuele Porru, Francesco Saverio Violante, Piera Versura

    Human tear analysis is gaining increasing attention as a non-invasive tool for several applications such as proteomics and biomarker identification in various diseases, including cancer. The choice of the correct sampling method determines the result of the analysis. In this study, we developed and validated a robust method for tear protein quantification using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS). Tear samples were collected with Schirmer strips, a low-cost and practical tool for tear collection. It is the first time that internal standards have been used to enhance the analytical performance of a method based on Schirmer strips for tear sampling, overcoming the issues widely reported in the literature regarding protein extraction and data reproducibility. Non-human proteins were used for method development, ensuring improved accuracy and analytical precision. The method demonstrated excellent recovery, high sensitivity, and reproducibility. The use of Schirmer strips, combined with this advanced analytical method, highlights their potential as a reliable support for tear protein quantification and biomarker discovery. This study provides a cost-effective and reliable workflow for tear proteome analysis and contributes to the growing field of tear-based diagnostics, making it suitable for routine clinical and research applications in precision medicine.


  • Open Access

    Microbiota–Gut–Brain Axis: Mass-Spectrometry-Based Metabolomics in the Study of Microbiome Mediators—Stress Relationship

    by Nicolò Interino, Rosalba Vitagliano, Federica D’amico, Raffaele Lodi, Emanuele Porru, Silvia Turroni, Jessica Fiori

    The microbiota–gut–brain axis is a complex bidirectional communication system that involves multiple interactions between intestinal functions and the emotional and cognitive centers of the brain. These interactions are mediated by molecules (metabolites) produced in both areas, which are considered mediators. To shed light on this complex mechanism, which is still largely unknown, a reliable characterization of the mediators is essential. Here, we review the most studied metabolites in the microbiota–gut–brain axis, the metabolic pathways in which they are involved, and their functions. This review focuses mainly on the use of mass spectrometry for their determination, reporting on the latest analytical methods, their limitations, and future perspectives. The analytical strategy for the qualitative–quantitative characterization of mediators must be reliable in order to elucidate the molecular mechanisms underlying the influence of the above-mentioned axis on stress resilience or vulnerability.


  • Open Access

    Analysis of Glucocorticoids as Potential Adulterants in Cosmetic Products: A Dual Approach for Qualitative and Quantitative Evaluation Based on ELISA and HPLC-MS Methods

    by Seyedeh Rojin Shariati Pour, Afsaneh Emamiamin, Martina Zangheri, Donato Calabria, Massimo Guardigli, Emanuele Porru, Jessica Fiori, Mara Mirasoli

    The analysis of cosmetic products represents an important field of analytical chemistry, since the demand for new formulations is continuously increasing. Regulations about prohibited/regulated compounds are applied in each country. Among the substances that are banned in cosmetics, corticosteroids represent a potential harm for consumers since the prolonged exposure to these compounds can affect health status. However, corticosteroids can be found in cosmetics as an illegal addition since they are able to alleviate the symptoms of inflammatory skin problems. In this work, two different approaches for detecting corticosteroids as potential adulterants in cosmetic products were compared. First, a reversed-phase HPLC-MS method was optimized and fully validated in order to identify and quantify eight corticosteroids (methylprednisolone, beclomethasone, flunisolide, budesonide, betamethasone 17-valerate, beclomethasone dipropionate, flumethasone, and dexamethasone). This reference method was then compared with an enzyme-linked immunosorbent assay (ELISA). Indeed, immunological techniques allow for rapid, low-cost, and sensitive detection of target analytes even in complex matrices, and they can be performed with simple instrumentation and by non-skilled personnel. The application of these methods on spiked cosmetic products was compared in terms of performance and advantages in order to evaluate the possibility of exploiting a complementary approach for optimizing the time for and costs of the analysis.


  • Open Access

    Sulfated Bile Acids in Serum as Potential Biomarkers of Disease Severity and Mortality in COVID-19

    by Emanuele Porru, Rossana Comito, Nicolò Interino, Andrea Cerrato, Marco Contoli, Paola Rizzo, Matteo Conti, Gianluca Campo, Savino Spadaro, Cristiana Caliceti, et al.

    The fight against coronavirus disease 2019 (COVID-19) continues. Since the pandemic’s onset, several biomarkers have been proposed to assess the diagnosis and prognosis of this disease. This research aimed to identify potential disease severity biomarkers in serum samples of patients with COVID-19 during the disease course. Data were collected using untargeted and targeted mass spectrometry methods. The results were interpreted by performing univariate and multivariate analyses. Important metabolite classes were identified by qualitative untargeted metabolomics in 15 serum samples from survivors of COVID-19. Quantitative targeted metabolomics on a larger patient cohort including 15 non-survivors confirmed serum 3-sulfate bile acids (i.e. GLCA-3S) were significantly increased in non-survivors compared to survivors during the early disease stage (p-value < 0.0001). Notably, it was associated with a higher risk of mortality (odds ratio of 26). A principal component analysis showed the ability to discriminate between survivors and non-survivors using the BA concentrations. Furthermore, increased BA-S is highly correlated with known parameters altered in severe clinical conditions.